Measurement of interleukin-6 levels and some of the hematological factors in individuals that suffering from Crohn's disease in Iraq
DOI:
https://doi.org/10.59746/jfms.v1i1.86Keywords:
IL-6, inflammatory bowel disease, Crohn’s disease.Abstract
The Crohn’s disease (CD), which is state of recurrent systemic infections with gut symptoms that are related to immunological issues, this disease typically affects the digestive system. The CD is a type of Inflammatory bowel disease (IBD). Patients with CD have a genetic background and are affected by environmental variables and the gut microbiome. A blood sample of 30 patients from Iraq with CD and thirty samples of healthy people as control were taken in this study during the period from Jul 2022 to Dec 2022. Gastro-Enterology and Hepatology Hospital in Baghdad, Iraq is the place that the blood samples were taken from. Hematological test was performed on all samples and also measurement of IL-6 levels in serum. The results of this study show significant differences in hematological factors between patients and control also in levels of IL-6. The conclusion of this study is that interlukine-6 plays part in the progression of CD by neutrophils are drawn to the site of inflammation, and furthermore neutrophils cause more damage to the same site.
References
• Baumgart, D. C. & Sandborn, W. J. 2012. Crohn's Disease. The Lancet, 380, 1590-1605. Doi: 10.1016/S0140-6736(12)60026-9
• Belaiche, J., Louis, E., D’haens, G., Cabooter, M., Naegels, S., De Vos, M., Fontaine, F., Schurmans, P., Baert, F. & De Reuck, M. 1999. Acute Lower Gastrointestinal Bleeding In Crohn’s Disease: Characteristics Of A Unique Series Of 34 Patients. The American Journal Of Gastroenterology, 94, 2177-2181. Https://Doi.Org/10.1016/S00029270(99)00347-0
• Gross, V., Andus, T., Caesar, I., Roth, M. & Schölmerich, J. 1992. Interleukin-6 Production In Crohn's Disease. Gastroenterology, 103, 1121. Doi: 10.1016/0016-5085(92)90098-
• Harbord, M., Annese, V., Vavricka, S. R., Allez, M., Barreiro-De Acosta, M., Boberg, K. M., Burisch, J., De Vos, M., De Vries, A.-M. & Dick, A. D. 2016. The First European Evidence-Based Consensus On Extra-Intestinal Manifestations In Inflammatory Bowel Disease. Journal Of Crohn's And Colitis, 10, 239-254. Https://Doi.Org/10.1093/Ecco-Jcc/Jjv213
• Hickey, M. J. & Kubes, P. 2009. Intravascular Immunity: The Host–Pathogen Encounter In Blood Vessels. Nature Reviews Immunology, 9, 364-375. Https://Doi.Org/10.1038/Nri2532
• Judge, T. A., Thoresen, C. J., Bono, J. E. & Patton, G. K. 2001. The Job Satisfaction–Job Performance Relationship: A Qualitative And Quantitative Review. Psychological Bulletin, 127, 376. Https://Doi.Org/10.1037/0033-2909.127.3.376
• Klenske, E., Bojarski, C., Waldner, M., Rath, T., Neurath, M. F. & Atreya, R. 2019. Targeting Mucosal Healing In Crohn’s Disease: What The Clinician Needs To Know. Therapeutic Advances In Gastroenterology, 12, 1756284819856865. Https://Doi.Org/10.1177/175628481985685
• Lichtenstein, G. R., Hanauer, S. B., Sandborn, W. J. & Gastroenterology, P. P. C. O. T. A. C. O. 2009. Management Of Crohn's Disease In Adults. Official Journal Of The American College Of Gastroenterology| Acg,104,465483. Doi:10.1038/Ajg.2008.168
• Neurath, M. F. 2014. Cytokines In Inflammatory Bowel Disease. Nature Reviews Immunology, 14, 329-342. Https://Doi.Org/10.1038/Nri3661
• Papadakis, K. A. & Targan, S. R. 2000. Role Of Cytokines In The Pathogenesis Of Inflammatory Bowel Disease. Annual Review Of Medicine, 51, 289-298.
• Petagna, L., Antonelli, A., Ganini, C., Bellato, V., Campanelli, M., Divizia, A., Efrati, C., Franceschilli, M., Guida, A. & Ingallinella, S. 2020. Pathophysiology Of Crohn’s Disease Inflammation And Recurrence. Biology Direct, 15, 1-10. Https://Doi.Org/10.1186/S13062-020-00280 5
• Sandborn, W. J., Feagan, B. G., Rutgeerts, P., Hanauer, S., Colombel, J.-F., Sands, B. E., Lukas, M., Fedorak, R. N., Lee, S. & Bressler, B. 2013. Vedolizumab As Induction And Maintenance Therapy For Crohn's Disease. New England Journal Of Medicine, 369, 711-721. Doi: 10.1056/Nejmoa1215739
• Schmitt, H., Neurath, M. F. & Atreya, R. 2021. Role Of The Il23/Il17 Pathway In Crohn’s Disease. Frontiers In Immunology, 12,622934.Https://Doi.Org/10.3389/Fimmu.2021.62294
• Seegert, D., Rosenstiel, P., Pfahler, H., Pfefferkorn, P., Nikolaus, S. & Schreiber, S. 2001. Increased Expression Of Il-16 In Inflammatory Bowel Disease. Gut, 48, 326. Doi: 10.1136/Gut.48.3.326
• Segal, A. W. 2018. The Role Of Neutrophils In The Pathogenesis Of Crohn's Disease. European Journal Of Clinical Investigation, 48, E12983. Https://Doi.Org/10.1111/Eci.12983
• Simpson, R. J., Hammacher, A., Smith, D. K., Matthews, J. M. & Ward, L. D. 1997. Interleukin‐6: Structure‐Function Relationships. Protein Science, 6, 929-955. Https://Doi.Org/10.1002/Pro.5560060501
• Tanaka, T., Narazaki, M. & Kishimoto, T. 2018. Interleukin (Il-6) Immunotherapy. Cold Spring Harbor Perspectives In Biology, 10,A028456.Doi:10.1101/Cshperspect.A028456
• Veauthier, B. & Hornecker, J. R. 2018. Crohn's Disease: Diagnosis And Management. American Family Physician, 98, 661-669 Doi: 10.1016/S0140-6736(16)31711-1.
• Veroux, M., Angriman, I., Ruffolo, C., Barollo, M., Buffone, A., Madia, C., Caglià, P., Fiamingo, P. & D'amico, D. 2003. Severe Gastrointestinal Bleeding In Crohn's Disease. Annali Italiani Di Chirurgia, 74, 213-5; Discussion 216. Doi: 10.1111/J.1572-0241.1999.01291.
• Wilson, A., Reyes, E. & Ofman, J. 2004. Prevalence And Outcomes Of Anemia In Inflammatory Bowel Disease: A Systematic Review Of The Literature. The American Journal Of Medicine, 116, 44-49. Https://Doi.Org/10.1016/J.Amjmed.2003.12.011
